Call Today for a FREE Consultation
Ball, Bonholtzer & Evans
Se Habla Español 626-817-6453

Takeda Nears Global Settlement In Actos Bladder Cancer Lawsuits

Takeda Pharmaceutical's impending global settlement in Actos bladder cancer lawsuits would be the first in four years of litigation over the diabetes drug.

According to confidential sources and as reported in today's Bloomberg News, Takeda Pharmaceutical Co. has indicated that it will pay more than $2.3 billion to settle the pending Actos lawsuits over bladder cancer claims. Asia's largest drugmaker tentatively agrees to settle more than 8,000   Actos bladder cancer lawsuits in federal and state courts in the U.S.

This global settlement would still have to ratified by Takeda's board of directors, and a board meeting is set to occur soon. Any settlement deal would average about $275,000 for each case, and would be the first in the four year old litigation over the diabetes drug. If approved, the global settlement may be announced at the next federal court hearing which is set for May 22. There are more than 4,000 federal personal injury, product liability lawsuits pending against Takeda Pharmaceuticals and Eli Lilly. The claims blame the companies for providing inadequate warnings about the risk of bladder cancer from Actos, a blockbuster type 2 diabetes drug. Louisiana Federal Multi-district Litigation Since December 2011, federal lawsuits have been centralized before U.S. District Judge Rebecca F. Doherty in the Western District of Louisiana, as part of an MDL, or Multi-District Litigation. It is common in mass tort pharmaceutical and medical device cases, that small groups of cases are prepared for early trial dates, known as "bellwether" cases. The first federal Actos trial ended in a record breaking $9 billion jury verdict last year. The jury found evidence that the drug makers deliberately destroyed documents about Actos and bladder cancer link. Takeda also deleted the files of 46 former and current employees, including those of top executives in Japan and U.S. sales representatives. Judge Doherty post verdict, reduced the punitive damage award in the case to $37 million. The case is on appeal. Originally posted by Shezad Malik on Actos Bladder Cancer Lawsuits - Ball & Bonholtzer Trial Attorney - Los Angeles

  • America's Top 100 Attorneys
  • Rated By SuperLawyers Stephen C. Ball 11 Years In A Row 2005-2006
  • American Board Of Trial Advocates
  • The National Top 100 Trial Lawyers Trial Lawyers
Email Us For A Response

Contact Us For The Help You Need

Bold labels are required.

Contact Information

The use of the Internet or this form for communication with the firm or any individual member of the firm does not establish an attorney-client relationship. Confidential or time-sensitive information should not be sent through this form.


Privacy Policy


Ball, Bonholtzer & Evans
300 North Lake Avenue Suite 1100
Pasadena, CA 91101

Phone: 626-817-6453
Fax: 626-793-3198
Pasadena Law Office Map